Vanderbilt Diabetes Center Archives
Pancreatlas provides access to complex images of the human pancreas
Dec. 22, 2020—Images of cells and tissues are a critical part of biomedical research as they show which molecules or proteins are present and where these molecules are located in the tissue. Using increasingly sophisticated microscopes and imaging approaches, scientists can now look at more than 40 different molecules at once, an approach known as multi-plex imaging, where in the past they could only look at three or four molecules at a time.
New tools to study bioactive lipids
Jul. 14, 2020—Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction.
VUSM students help patients, clinicians with telehealth
Apr. 23, 2020—When in-person visits to Vanderbilt Eskind Diabetes Clinic needed to be quickly converted to telehealth appointments in response to COVID-19, a novel solution was hatched to bring both clinicians and patients up to speed on videoconferencing.
Metabolism expert Lazar set for next Discovery Lecture
Sep. 12, 2019—Endocrinologist Mitchell Lazar, MD, PhD, known for his work on the genetic regulation of metabolism, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 19.
Research explores link between stem cell transplant, diabetes
Jan. 17, 2019—About a decade ago, at the beginning of his career in academic medicine, Brian Engelhardt, MD, MSCI, noticed that many of his patients receiving a stem cell transplant for their blood cancer ended up with diabetes.
Study points to alternate therapy for rare form of diabetes
Jan. 17, 2019—Vanderbilt University Medical Center researchers say an unexpected finding during the cellular analysis of human pancreatic tissue has revealed new information about a rare type of diabetes and underscores the importance of genetic testing for some individuals diagnosed with type 1 diabetes.
Beta cell biomarker findings may speed diabetes research
Nov. 29, 2018—Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding, reported this month in the journal Cell Metabolism, could lead to improved ways to study and treat diabetes.
First Islet Workshop draws international audience
Sep. 13, 2018—More than 200 investigators from across the globe who specialize in islet biology, the study of hormone-producing cell clusters in the pancreas known as islets, recently gathered in Nashville to share knowledge and present the challenges and successes of their work during the first Islet Biology Workshop at Vanderbilt.
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Mar. 6, 2018—Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).
Telemedicine simplifies gestational diabetes treatment
Dec. 7, 2017—When 32-year-old Dana Shaw was diagnosed with gestational diabetes mellitus (GDM) during her pregnancy with her first child, she was happy to learn she could meet with a physician about the condition through video conferencing rather than taking time off from work for an appointment.
American Diabetes Association honors Granner’s achievements
Jun. 1, 2017—Daryl Granner, M.D., professor of Molecular Physiology and Biophysics, emeritus, at Vanderbilt, has been recognized for outstanding achievements in diabetes research and training by the American Diabetes Association.
Patient day seminar
Feb. 23, 2017—The Vanderbilt Eskind Diabetes Center hosted a Multiple Endocrine Neoplasia Patient Day Seminar earlier this month, with 60-70 attendees from all over the United States gathering to learn more about the condition and its treatment.
